Announcements Trials

Browse Landscape

Phase

Status

Not yet recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Breast Neoplasms 7 Surgical Wound Infection 5 Pilonidal Sinus 3 Wound Infection 2 Sarcoma 2 Thyroid Nodule 1 Thyroid Neoplasms 1 Thyroid Diseases 1 Spinal Cord Injuries 1 Skin Neoplasms 1 Skin Carcinoma 1 Seroma 1 Postoperative Complications 1 Obesity 1 Non-melanoma Skin Cancer 1 Neoplasm Metastasis 1 Infections 1 Graves Disease 1 Goiter 1 Esophageal Neoplasms 1 Anastomotic Leak 1 Adenocarcinoma 1

Interventions

Oxaliplatin 32 Fluorouracil 24 Gemcitabine 23 Leucovorin 19 Docetaxel 19 pembrolizumab 17 Capecitabine 15 Radiotherapy 14 Irinotecan 13 Cisplatin 11 Bevacizumab 11 Nivolumab 8 130-nm albumin-bound paclitaxel 8 Trastuzumab 7 Erlotinib Hydrochloride 7 Cyclophosphamide 7 Albumin-Bound Paclitaxel 7 Radiosurgery 6 Paclitaxel 6 Taxes 5 S 1 (combination) 5 Metformin 5 Carboplatin 5 Blood Specimen Collection 5 Sunitinib 4 Sorafenib 4 Pemetrexed 4 Esophagectomy 4 Chemoradiotherapy 4 Cetuximab 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

OTHER × Adenocarcinoma × Negative-Pressure Wound Therapy × Clear all

NCT07489820 2026-05-22

AAPICO

Centre Hospitalier Departemental Vendee

Phase NA Not yet recruiting

Adenocarcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡